Likewise, DD-Kir2.1 was significantly upregulated at the site of expression only 8h after shield1 treatment and is in accordance to previously published findings on shield1-mediated secretion of cytokines in a cancer mouse model6. This evidence concerns the gene KCNJ2 and cancer.